Adalimumab for treatment of pyoderma gangrenosum
Authors:
- 4 October 2007
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 157 (6) , 1274-1275
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Adalimumab Treatment for Pyoderma GangrenosumArchives of Dermatology, 2007
- Problems encountered during anti-tumour necrosis factor therapyBest Practice & Research Clinical Rheumatology, 2006
- The treatment of pyoderma gangrenosum using etanerceptJournal of the American Academy of Dermatology, 2006
- Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trialGut, 2005
- Systemic pyoderma gangrenosum responding to infliximab and adalimumabBritish Journal of Dermatology, 2005
- A Pilot Study of Adalimumab in Infliximab-Allergic PatientsInflammatory Bowel Diseases, 2004
- Adalimumab (HumiraTM): a brief review for dermatologistsJournal of Dermatological Treatment, 2004
- Safety of Tumour Necrosis Factor-?? AntagonistsDrug Safety, 2004